<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03997500</url>
  </required_header>
  <id_info>
    <org_study_id>Yi Chen</org_study_id>
    <nct_id>NCT03997500</nct_id>
  </id_info>
  <brief_title>Prophylactic Norepinephrine Infusion for Spinal Hypotension and Inferior Vena Cava Collapsibility Index</brief_title>
  <official_title>Prophylactic Norepinephrine Infusion for Spinal Hypotension and Inferior Vena Cava Collapsibility Index During Cesarean Delivery: a Randomized Double Blinded Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital of Ningxia Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General Hospital of Ningxia Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the preventive effect of norepinephrine on
      post-spinal hypotension and the effect of norepinephrine on inferior vena cava collapsibility
      index (IVC-CI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-spinal hypotension is a frequent complication during spinal anesthesia for cesarean
      delivery. It affects nearly 50-60% of patients without appropriately treat. Vasopressors has
      been highly recommended for routine prevention and/or treatment of post-spinal hypotension.
      Norepinephrine is new vasopressor that has been suggested as a potential alternative to
      phenylephrine and was recently introduced in obstetric anesthesia because of the minimal
      cardiac depressant effect. The purpose of this study is to investigate the preventive effect
      of norepinephrine on post-spinal hypotension and the effect on inferior vena cava
      collapsibility index (IVC-CI).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">October 21, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of hypotension</measure>
    <time_frame>1 to 20 minutes after subarachnoid block</time_frame>
    <description>SBP decreased to &lt;80% of the baseline value</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inferior vena cava collapsibility index</measure>
    <time_frame>5 to 20 minutes after subarachnoid block</time_frame>
    <description>CI = (dIVCmax - dIVCmin)/dIVCmax</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of nausea and vomiting</measure>
    <time_frame>1 to 20 minutes after subarachnoid block</time_frame>
    <description>Presence of nausea and vomiting in patients after subarachnoid block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of bradycardia</measure>
    <time_frame>1 to 20 minutes after subarachnoid block</time_frame>
    <description>Heart rate less than 55 bpm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of hypertension</measure>
    <time_frame>1 to 20 minutes after subarachnoid block</time_frame>
    <description>Systolic blood pressure at or above 120% of baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial base excess of fetal vein blood</measure>
    <time_frame>Immediately after delivery</time_frame>
    <description>From umbilical vein blood gases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pressure of oxygen of fetal vein blood</measure>
    <time_frame>Immediately after delivery</time_frame>
    <description>From umbilical vein blood gases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pH value of fetal vein blood</measure>
    <time_frame>Immediately after delivery</time_frame>
    <description>From umbilical vein blood gases</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of rescue norepinephrine</measure>
    <time_frame>Immediately to 20 minutes after subarachnoid block</time_frame>
    <description>a bolus of norepinephrine was given when SBP decreased to &lt;80% of the baseline value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APGAR score</measure>
    <time_frame>1min after delivery</time_frame>
    <description>A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APGAR score</measure>
    <time_frame>5min after delivery</time_frame>
    <description>A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>APGAR score</measure>
    <time_frame>10min after delivery</time_frame>
    <description>A= Appearance P=Pulse G=Grimace A=Attitude R=Respiration</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">195</enrollment>
  <condition>Adverse Effect</condition>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Simultaneous with subarachnoid block, a bolus of normal saline was given followed by normal saline infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Norepinephrine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Simultaneous with subarachnoid block, a bolus of norepinephrine was given followed by norepinephrine infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>a bolus of normal saline was given followed by normal saline infusion</description>
    <arm_group_label>Normal saline</arm_group_label>
    <other_name>NS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norepinephrine</intervention_name>
    <description>a bolus of norepinephrine was given followed by norepinephrine infusion</description>
    <arm_group_label>Norepinephrine</arm_group_label>
    <other_name>Vasopressors</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-45 years

          -  American Society of Anesthesiologists physical status classification I to II

          -  Scheduled for elective cesarean delivery under spinal anesthesia

          -  Full-term, singleton, pregnant women

        Exclusion Criteria:

          -  Height of no more than 150 centimeters

          -  Body weight greater than 100 kg or BMI greater than 30

          -  Labor analgesia had been performed

          -  Contraindication of spinal or epidural anesthesia

          -  Eclampsia or chronic hypertension or baseline blood pressure ≥160mmHg

          -  Hemoglobin ＜7g/dl

          -  Fetal distress or known abnormal fetal development

          -  Severe vascular disease

          -  Diabetes mellitus or cardiovascular disease or nervous system disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xinli Ni, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>xinlini6@yahoo.com</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>General Hospital of Ningxia Medical University</name>
      <address>
        <city>Yinchuan</city>
        <state>Ningxia</state>
        <zip>750004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 28, 2019</study_first_submitted>
  <study_first_submitted_qc>June 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2019</study_first_posted>
  <last_update_submitted>February 13, 2020</last_update_submitted>
  <last_update_submitted_qc>February 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Norepinephrine</keyword>
  <keyword>Hypotension</keyword>
  <keyword>Inferior Vena Cava Collapsibility Index</keyword>
  <keyword>Cesarean Delivery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Norepinephrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

